![](/img/cover-not-exists.png)
(343) Oliceridine (TRV130), a novel μ receptor G protein pathway selective modulator (μ-GPS), demonstrates a predictable relationship between plasma concentrations and pain relief. II: simulation of potential dosing regimens using a pharmacokinetic/pharmacodynamic (PK/PD) model
Fossler, M., Sadler, B., Farrell, C., Burt, D., Pitsiu, M., Skobieranda, F., Soergel, D.Volume:
17
Language:
english
Journal:
The Journal of Pain
DOI:
10.1016/j.jpain.2016.01.250
Date:
April, 2016
File:
PDF, 38 KB
english, 2016